Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA AB et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
Case Number:
3:14-cv-04782
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 16, 2017
AstraZeneca, Zydus Reach Deal To End Nexium IP Suit
AstraZeneca AB and Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, have settled a New Jersey federal lawsuit alleging that Zydus' plans to manufacture generic versions of Nexium infringe AstraZeneca's patents on the heartburn drug.
-
August 01, 2014
AstraZeneca Sues Zydus To Block Generic Nexium
AstraZeneca AB hit Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, with a lawsuit Thursday in New Jersey federal court claiming Zydus' plans to manufacture generic Nexium infringes on AstraZeneca's patents on the popular heartburn drug.